Erin Borger
Directeur Général chez ExThera Medical Corp.
Postes actifs de Erin Borger
Sociétés | Poste | Début | Fin |
---|---|---|---|
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Directeur/Membre du Conseil | - | - |
Directeur Général | 15/11/2023 | - |
Historique de carrière de Erin Borger
Anciens postes connus de Erin Borger
Sociétés | Poste | Début | Fin |
---|---|---|---|
LONGEVERON INC. | Directeur/Membre du Conseil | 12/02/2021 | 09/06/2023 |
Independent Dir/Board Member | 12/02/2021 | 09/06/2023 | |
National Parkinson Foundation, Inc. | Directeur/Membre du Conseil | 12/01/2014 | - |
Formation de Erin Borger
Wofford College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Entreprise privées | 2 |
---|---|
National Parkinson Foundation, Inc. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
- Bourse
- Insiders
- Erin Borger
- Expérience